Dual effects of the Nrf2 inhibitor for inhibition of hepatitis C virus and hepatic cancer cells
Background We previously showed that knockdown of nuclear factor E2-related factor 2 (Nrf2) resulted in suppression of hepatitis C virus (HCV) infection.
Yuko Murakami +16 more
doaj +1 more source
Objectives To observe the protective effects of dexmedetomidine (Dex) postconditioning on myocardial ischemia/reperfusion injury (IRI) and to explore its potential molecular mechanisms.Methods One-hundred forty-seven male Sprague-Dawley rats were ...
Bin Hu +9 more
doaj +1 more source
Targeting the NRF2/HO-1 Antioxidant Pathway in FLT3-ITD-Positive AML Enhances Therapy Efficacy
Acute myeloid leukemia (AML) is a molecularly heterogenous hematological malignancy, with one of the most common mutations being internal tandem duplication (ITD) of the juxtamembrane domain of the fms-like tyrosine kinase receptor-3 (FLT3).
Sankaranarayan Kannan +10 more
doaj +1 more source
Larvicidal Activity of Brusatol Isolated from Brucea javanica (L) Merr on Culex quinquefasciatus
Background: Vector control is still emphasized on the using of chemical insecticide which can cause death of non-target organisms, pollution and vector resistance.
Dwi SUTININGSIH +3 more
doaj +1 more source
Effects of grape seed proanthocyanidin B2 pretreatment on oxidative stress and renal tubular epithelial cell apoptosis after renal ischemia reperfusion in mice [PDF]
Purpose To investigate the effects of grape seed proanthocyanidin B2 (GSPB2) preconditioning on oxidative stress and apoptosis of renal tubular epithelial cells in mice after renal ischemia-reperfusion (RIR).
Zhi-shun Wang +4 more
doaj +1 more source
Brusatol Suppresses Bladder Cancer by downregulating the expression of Nrf2
Abstract A substance called brunsatol, which is derived from the dried ripe fruit of Brucea javanica, has been shown to be active against a variety of human cancers, but not against bladder cancer (BCa). In the present study, we attempted to investigate the effect of brusatol in BCa and verify whether Nrf2 was involved in the mechanism.
Xi Yu +5 more
openaire +1 more source
Brusatol Inhibits Tumor Growth and Increases the Efficacy of Cabergoline against Pituitary Adenomas [PDF]
Cabergoline (CAB) is the first choice for treatment of prolactinoma and the most common subtype of pituitary adenoma. However, drug resistance and lack of effectiveness in other pituitary tumor types remain clinical challenges to this treatment. Brusatol (BT) is known to inhibit cell growth and promote apoptosis in a variety of cancer cells.
Zerui Wu +7 more
openaire +2 more sources
Brusatol derivative-34 (Bru-34), a derivative of brusatol, has been shown significantly anti-inflammatory activity in mice in our previously work. However, to our knowledge, there were very limited studies on how Bru-34 affected airway inflammation. Thus,
Yasi Ding +8 more
doaj +1 more source
Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism [PDF]
The major obstacle in cancer treatment is the resistance of cancer cells to therapies. Nrf2 is a transcription factor that regulates a cellular defense response and is ubiquitously expressed at low basal levels in normal tissues due to Keap1-dependent ubiquitination and proteasomal degradation.
Dongmei, Ren +6 more
openaire +2 more sources
Synergistic antitumor effect of brusatol combined with cisplatin on colorectal cancer cells
Colorectal cancer (CRC) is a common and life‑threatening type of malignant cancer, which is associated with a high mortality rate. Cisplatin (CDDP) is a commonly used chemotherapy drug with significant side effects. Brusatol (BR) is one of the principal chemical compounds isolated from the Chinese herb Bruceae Fructus, which has been reported to ...
Chen, Hai-Ming +8 more
openaire +3 more sources

